Insights On Drug Development
-
Quantitation Of Monoclonal Antibodies In Serum
2/8/2024
Monoclonal antibodies (mAbs) are a rapidly growing group of targeted therapeutics. Gain insight into the importance of optimized bioanalytical assay platforms for mAb development.
-
Metabolite And Nutrient Analysis As Crucial Components For Optimal Upstream Process
2/8/2024
Discover how insights into cell metabolism can further enable the development of efficient cell culture processes through tailored nutrient supplementation and monitoring.
-
Development And Regulation Of Veterinary Monoclonals
2/8/2024
Although veterinary mAbs have achieved commercial success, ongoing discussions and clinical developments surrounding them are expected to outline a clear regulatory pathway in the near future.
-
The Latest Trends In The Prevention And Treatment Of Cervical Cancer
2/8/2024
Unearth what immune checkpoint inhibitors are showing promise in treating cervical cancer and how advancements in these treatments paired with additional prevention strategies are improving patient outcomes.
-
Advancing Your API To First Human Dose Trials More Efficiently
2/7/2024
Learn how end-to-end support for development and manufacturing, clinical trial services, advanced drug delivery, and commercial packaging can accelerate drug development and time to market.
-
Adopting Modular, Semi-Automated Approaches To Optimize CGT Development
2/7/2024
There are a number of technology solutions that, when applied to a cell and gene therapy workflow, can streamline development and improve workflow integration.
-
Getting Genomic Medicines Ready For Prime Time
2/5/2024
Explore the benefits of building a manufacturing process early, how research into LNPs in nucleic acid therapeutics will contribute to the development of future drugs, and more.
-
Optimizing Sialic Acid Clone Screening Through A High-Throughput Lectin Assay
2/2/2024
While the traditional high-performance analytical methods used to evaluate glycosylation offer operators high accuracy, their throughput limitations can create time and cost constraints that may hinder development.
-
Closing The Gap Between Theory And Therapy
1/30/2024
A molecule with great therapeutic potential is only as good as its formulation. For patients, a successful formulation closes the gap between theory and therapy.
-
Reducing Risk For Commercial Manufacturing Of Cell And Gene Therapies
1/25/2024
For any biotherapeutic in development today, a critical element in achieving commercialization is reducing manufacturing risk.